Linda Gorgos
Internal Medicine · Santa Fe, NMNPI 1124138540
Payments from drug & device makers
Across 459 payments — averaging $9485.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.8M
- Gilead$774K
- Regeneron$448K
- Roche Molecular Systems, Inc.$403K
- Viiv Healthcare Company$242K
- GSK$225K
- plus $505K from 7 others
Across 23 payments — averaging $136.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 94 | $1,756,428 |
| Gilead | 110 | $774,191 |
| Regeneron | 31 | $447,811 |
| Roche Molecular Systems, Inc. | 25 | $403,032 |
| Viiv Healthcare Company | 65 | $242,322 |
| GSK | 44 | $225,032 |
| Modernatx, Inc. | 31 | $126,944 |
| Novavax Inc | 19 | $115,722 |
| Quidel Corporation | 2 | $115,000 |
| Pfizer | 13 | $67,558 |
| Janssen Research & Development, LLC | 17 | $30,464 |
| AbbVie | 7 | $28,348 |
| AstraZeneca | 1 | $21,200 |
How this compares
$4,354,053 in reported general payments places this provider in the 95th percentile of 578 internal medicine providers in New Mexico.
Other internal medicine in Santa Fe
- John ReddSanta Fe$12K
- Mark SeredowychSanta Fe$9K
- Joshua BrownSanta Fe$9K
- Michelle ValentineAlbuquerque$12.7M
- Edward LewieckiAlbuquerque$1.5M
- Lance RudolphAlbuquerque$980K
- Yordan Orive GomezArtesia$611K
- Michelle IandiorioAlbuquerque$349K
- Nour Ass'adAlbuquerque$332K
- Joao TeixeiraAlbuquerque$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.